Pronase treatment enhances the sensitivity of B cell flow cytometry crossmatch: A single-center data analysis
Authors:
- 30 October 2025
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 93, 102325
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From IstanbulTransplantation Proceedings, 2023
- Abrogating biologics interference in flow cytometric crossmatchingHuman Immunology, 2021
- Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 casesJournal of Immunoassay and Immunochemistry, 2020
- Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocolsHuman Immunology, 2018
- Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary targetHuman Immunology, 2017
- Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patientsHuman Immunology, 2016
- Interference of therapeutic antibodies used in desensitization protocols on lymphocytotoxicity crossmatch resultsTransplant Immunology, 2015
- Frequent False-Positive Reactions in Pronase-Treated T-Cell Flow Cytometric Cross-match TestsTransplantation Proceedings, 2012
- Impact of pronase on flow cytometric crossmatch outcomeHuman Immunology, 2011
- New Crossmatch Technique Eliminates Interference by Humanized and Chimeric Monoclonal AntibodiesTransplantation Proceedings, 2005